Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic Plague.

PST Yersinia pestis antibiotic resistance antibiotic therapy ceftriaxone phage therapy phage–antibiotic combination plague фA1122

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
26 03 2022
Historique:
received: 01 03 2022
revised: 23 03 2022
accepted: 24 03 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 27 4 2022
Statut: epublish

Résumé

Plague pandemics and outbreaks have killed millions of people during the history of humankind. The disease, caused by the bacteria

Identifiants

pubmed: 35458417
pii: v14040688
doi: 10.3390/v14040688
pmc: PMC9024586
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Antimicrob Agents Chemother. 2006 Oct;50(10):3233-6
pubmed: 17005799
Antimicrob Agents Chemother. 1998 Mar;42(3):675-81
pubmed: 9517950
J Med Microbiol. 2019 Mar;68(3):292-302
pubmed: 30632956
Clin Infect Dis. 2022 Mar 1;74(4):695-702
pubmed: 34244722
Biomolecules. 2021 May 12;11(5):
pubmed: 34065940
Viruses. 2021 Sep 11;13(9):
pubmed: 34578390
Viruses. 2021 Jun 29;13(7):
pubmed: 34209836
Cell Host Microbe. 2019 Feb 13;25(2):219-232
pubmed: 30763536
PLoS One. 2007 Mar 21;2(3):e309
pubmed: 17375195
JAMA. 2000 May 3;283(17):2281-90
pubmed: 10807389
Antimicrob Agents Chemother. 2015 Apr;59(4):1919-21
pubmed: 25583720
NPJ Vaccines. 2018 Oct 19;3:52
pubmed: 30374415
Sci Rep. 2018 Feb 2;8(1):2326
pubmed: 29396496
Microorganisms. 2021 Jul 19;9(7):
pubmed: 34361970
PLoS Pathog. 2015 May 14;11(5):e1004893
pubmed: 25974210
Emerg Infect Dis. 2001 Jan-Feb;7(1):43-8
pubmed: 11266293
Front Microbiol. 2016 May 19;7:763
pubmed: 27242774
Bacteriophage. 2012 Jul 1;2(3):186-189
pubmed: 23282533
MMWR Recomm Rep. 2021 Jul 16;70(3):1-27
pubmed: 34264565
PLoS One. 2011;6(9):e25486
pubmed: 21980477
Trends Microbiol. 2016 Mar;24(3):190-197
pubmed: 26698952
Sci Rep. 2020 Jan 15;10(1):307
pubmed: 31941920
Curr Opin Biotechnol. 2021 Apr;68:151-159
pubmed: 33310655
J Bacteriol. 2011 Sep;193(18):4963-72
pubmed: 21764935
Microbiol Mol Biol Rev. 2019 Oct 30;83(4):
pubmed: 31666296
Lancet Infect Dis. 2019 May;19(5):537-545
pubmed: 30930106
Adv Exp Med Biol. 2016;918:361-375
pubmed: 27722870
Int J Biol Sci. 2021 Aug 18;17(13):3573-3582
pubmed: 34512166
Front Cell Infect Microbiol. 2019 Feb 18;9:22
pubmed: 30834237
Antimicrob Agents Chemother. 2017 Sep 22;61(10):
pubmed: 28807909
Adv Exp Med Biol. 2012;954:337-48
pubmed: 22782780
Bioessays. 2015 Jan;37(1):6-9
pubmed: 25521633
Front Microbiol. 2018 Apr 24;9:741
pubmed: 29740404
Comput Biol Med. 2022 Mar;142:105186
pubmed: 34998221
Proc (Bayl Univ Med Cent). 2005 Apr;18(2):116-24
pubmed: 16200159
J Infect Dis. 2019 Aug 30;220(7):1147-1151
pubmed: 31095689
Clin Infect Dis. 2019 Nov 13;69(11):2015-2018
pubmed: 30869755
Viruses. 2021 Jan 11;13(1):
pubmed: 33440682
Vaccines (Basel). 2022 Jan 19;10(2):
pubmed: 35214604
Bull N Y Acad Med. 1931 May;7(5):329-48
pubmed: 19311785

Auteurs

Yaron Vagima (Y)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, Israel.

David Gur (D)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, Israel.

Moshe Aftalion (M)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, Israel.

Sarit Moses (S)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, Israel.

Yinon Levy (Y)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, Israel.

Arik Makovitzki (A)

Department of Biotechnology, Israel Institute for Biological Research, Ness-Ziona 74100, Israel.

Tzvi Holtzman (T)

Department of Biotechnology, Israel Institute for Biological Research, Ness-Ziona 74100, Israel.

Ziv Oren (Z)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, Israel.

Yaniv Segula (Y)

Department of Biotechnology, Israel Institute for Biological Research, Ness-Ziona 74100, Israel.

Ella Fatelevich (E)

Department of Biotechnology, Israel Institute for Biological Research, Ness-Ziona 74100, Israel.

Avital Tidhar (A)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, Israel.

Ayelet Zauberman (A)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, Israel.

Shahar Rotem (S)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, Israel.

Emanuelle Mamroud (E)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, Israel.

Ida Steinberger-Levy (I)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH